Isocitrate Dehydrogenase Mutation and (<i>R</i>)-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development
The identification of heterozygous mutations in the metabolic enzyme isocitrate dehydrogenase (IDH) in subsets of cancers, including secondary glioblastoma, acute myeloid leukem...